Clinical Trial Update: A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing cefdinir to cephalexin for mild to moderate uncomplicated skin and skin structure infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin and Soft Tissue Infection

Drugs mentioned

• Cefdinir (cefdinir)
• Cephalexin (Cephalexin)

Snippet

Sponsor: Abbott | Conditions: Mild to Moderate Uncomplicated Skin and Skin Structure Infections | Phase 4 | Status: COMPLETED